These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Allogeneic peripheral blood stem cell transplantation for high-risk leukemia]. Huang X, Wang F, Guo N. Zhonghua Yi Xue Za Zhi; 2001 Nov 25; 81(22):1348-51. PubMed ID: 11930625 [Abstract] [Full Text] [Related]
3. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation. Lemoli RM, Bandini G, Leopardi G, Rosti G, Bonini A, Fortuna A, Rondelli D, Mangianti S, Motta MR, Rizzi S, Tassi C, Cavo M, Remiddi C, Curti A, Conte R, Tura S. Haematologica; 1998 Jan 25; 83(1):48-55. PubMed ID: 9542323 [Abstract] [Full Text] [Related]
4. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia]. Tong XZ, Li J, Tan EX, Zhang GC, Wu XY, Peng AH, Zheng D, Zou WY, Hong WD, Luo SK. Zhonghua Zhong Liu Za Zhi; 2006 Jul 25; 28(7):545-8. PubMed ID: 17147125 [Abstract] [Full Text] [Related]
5. [Induction of aGVHD after allogeneic hematopoietic stem cell transplantation for refractory or relapsed acute leukemia]. Sun J, Meng FY, Liu QF, Xu D, Xu B, Liu XL. Ai Zheng; 2003 Dec 25; 22(12):1321-4. PubMed ID: 14693060 [Abstract] [Full Text] [Related]
10. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia. Kröger N, Bornhäuser M, Ehninger G, Schwerdtfeger R, Biersack H, Sayer HG, Wandt H, Schäfer-Eckardt K, Beyer J, Kiehl M, Zander AR, German Cooperative Transplant Study Group. Ann Hematol; 2003 Jun 25; 82(6):336-42. PubMed ID: 12728337 [Abstract] [Full Text] [Related]
12. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia. Shigematsu A, Kondo T, Yamamoto S, Sugita J, Onozawa M, Kahata K, Endo T, Shiratori S, Ota S, Obara M, Wakasa K, Takahata M, Takeda Y, Tanaka J, Hashino S, Nishio M, Koike T, Asaka M, Imamura M. Biol Blood Marrow Transplant; 2008 May 25; 14(5):568-75. PubMed ID: 18410899 [Abstract] [Full Text] [Related]
13. Allogeneic peripheral blood stem cell transplantation for leukemia. Zhu K, Xu Y, Wu D, Xu X, Huang L. Chin Med J (Engl); 2001 May 25; 114(5):493-6. PubMed ID: 11780411 [Abstract] [Full Text] [Related]
14. [Clinical study of allogeneic hematopoietic stem cell transplantation for relapsed/refractory acute lymphocytic leukemia]. Ma X, Wu DP, Sun AN, Fu ZZ, Tang XW, Wu XJ, Liu YJ, Qiu HY, Miao M, Han Y, Jin ZM, Zhao Y, Xue SL, Wang Y, Chen SN, He GS, Zhou HX, Chang HR. Zhonghua Xue Ye Xue Za Zhi; 2009 Feb 25; 30(2):73-6. PubMed ID: 19563014 [Abstract] [Full Text] [Related]
15. Impact of postgrafting immunosuppressive regimens on nonrelapse mortality and survival after nonmyeloablative allogeneic hematopoietic stem cell transplant using the fludarabine and low-dose total-body irradiation 200-cGy. Koh LP, Chen CS, Tai BC, Hwang WY, Tan LK, Ng HY, Linn YC, Koh MB, Goh YT, Tan B, Lim S, Lee YM, Tan KW, Liu TC, Ng HJ, Loh YS, Mow BM, Tan DC, Tan PH. Biol Blood Marrow Transplant; 2007 Jul 25; 13(7):790-805. PubMed ID: 17580257 [Abstract] [Full Text] [Related]